Christopher M Verdier
Examiner (ID: 1476, Phone: (571)272-4824 , Office: P/3745 )
Most Active Art Unit | 3745 |
Art Unit(s) | 3401, 2851, 3745, 2899 |
Total Applications | 2960 |
Issued Applications | 2317 |
Pending Applications | 150 |
Abandoned Applications | 493 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 16376525
[patent_doc_number] => 20200325367
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => LENS ADHESIVE, CEMENTED LENS, AND IMAGING MODULE
[patent_app_type] => utility
[patent_app_number] => 16/912073
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16556
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 624
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912073
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/912073 | Lens adhesive, cemented lens, and imaging module | Jun 24, 2020 | Issued |
Array
(
[id] => 17968194
[patent_doc_number] => 11485708
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-01
[patent_title] => Compounds for treatment of PD-L1 diseases
[patent_app_type] => utility
[patent_app_number] => 16/905979
[patent_app_country] => US
[patent_app_date] => 2020-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19544
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 923
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16905979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/905979 | Compounds for treatment of PD-L1 diseases | Jun 18, 2020 | Issued |
Array
(
[id] => 18837704
[patent_doc_number] => 11845767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-12-19
[patent_title] => Arginase inhibitors
[patent_app_type] => utility
[patent_app_number] => 17/617065
[patent_app_country] => US
[patent_app_date] => 2020-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12480
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617065
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617065 | Arginase inhibitors | Jun 14, 2020 | Issued |
Array
(
[id] => 16511509
[patent_doc_number] => 20200390766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => PHARMACEUTICAL COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/899638
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899638
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899638 | PHARMACEUTICAL COMPOSITION | Jun 11, 2020 | Abandoned |
Array
(
[id] => 17044877
[patent_doc_number] => 11098045
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-24
[patent_title] => Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/899116
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 10
[patent_no_of_words] => 42850
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 500
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899116
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899116 | Haloallylamine indole and azaindole derivative inhibitors of lysyl oxidases and uses thereof | Jun 10, 2020 | Issued |
Array
(
[id] => 18383658
[patent_doc_number] => 11654424
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-05-23
[patent_title] => Method embodiments for making lanthanide metal complexes from lanthanide metal oxides and separating the same from heavy lanthanide metal oxides, actinide oxides, and non-lanthanide rare earth element oxides
[patent_app_type] => utility
[patent_app_number] => 16/898253
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8518
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898253
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/898253 | Method embodiments for making lanthanide metal complexes from lanthanide metal oxides and separating the same from heavy lanthanide metal oxides, actinide oxides, and non-lanthanide rare earth element oxides | Jun 9, 2020 | Issued |
Array
(
[id] => 17236579
[patent_doc_number] => 11180450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Substituted indoline derivatives as dengue viral replication inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/893685
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17626
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/893685 | Substituted indoline derivatives as dengue viral replication inhibitors | Jun 4, 2020 | Issued |
Array
(
[id] => 17704460
[patent_doc_number] => 20220204466
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-06-30
[patent_title] => PROCESS FOR MANUFACTURING HYDROXYMETHYLFURFURAL
[patent_app_type] => utility
[patent_app_number] => 17/609670
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3991
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609670 | PROCESS FOR MANUFACTURING HYDROXYMETHYLFURFURAL | Jun 3, 2020 | Abandoned |
Array
(
[id] => 17896933
[patent_doc_number] => 20220306595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => LIGAND-ENABLED BETA-C(sp3)-H LACTONIZATION FOR BETA-C-H FUNCTIONALIZATIONS
[patent_app_type] => utility
[patent_app_number] => 17/615509
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615509
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615509 | Ligand-enabled b-C(sp | May 28, 2020 | Issued |
Array
(
[id] => 16283715
[patent_doc_number] => 20200277317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-03
[patent_title] => CRYSTAL OF CYCLIC PHOSPHONIC ACID SODIUM SALT AND METHOD FOR MANUFACTURING SAME
[patent_app_type] => utility
[patent_app_number] => 16/877915
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29444
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877915
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877915 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | May 18, 2020 | Issued |
Array
(
[id] => 18701274
[patent_doc_number] => 11787773
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-17
[patent_title] => Process for the production of furfural
[patent_app_type] => utility
[patent_app_number] => 17/605778
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5774
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17605778
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/605778 | Process for the production of furfural | May 18, 2020 | Issued |
Array
(
[id] => 16681703
[patent_doc_number] => 10941169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same
[patent_app_type] => utility
[patent_app_number] => 16/878109
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 29466
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16878109
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/878109 | Crystal of cyclic phosphonic acid sodium salt and method for manufacturing same | May 18, 2020 | Issued |
Array
(
[id] => 17029640
[patent_doc_number] => 11091445
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-17
[patent_title] => Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders
[patent_app_type] => utility
[patent_app_number] => 15/930990
[patent_app_country] => US
[patent_app_date] => 2020-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 16488
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15930990
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/930990 | Compounds, process for obtaining the compounds, pharmaceutical composition, use of the compounds and method for treating psychiatric disorders and/or sleep disorders | May 12, 2020 | Issued |
Array
(
[id] => 17460181
[patent_doc_number] => 20220073486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => METHOD FOR SYNTHESIZING MYRICETIN
[patent_app_type] => utility
[patent_app_number] => 17/428919
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1703
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428919
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428919 | Method for synthesizing myricetin | May 7, 2020 | Issued |
Array
(
[id] => 16390903
[patent_doc_number] => 20200331844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => METABOLISM RESISTANT FENFLURAMINE ANALOGS AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/870128
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16870128
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/870128 | Metabolism resistant fenfluramine analogs and methods of using the same | May 7, 2020 | Issued |
Array
(
[id] => 17953462
[patent_doc_number] => 11479553
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-10-25
[patent_title] => 5-5 fused rings as C5a inhibitors
[patent_app_type] => utility
[patent_app_number] => 16/865648
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22434
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 539
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16865648
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/865648 | 5-5 fused rings as C5a inhibitors | May 3, 2020 | Issued |
Array
(
[id] => 17281680
[patent_doc_number] => 11198700
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-14
[patent_title] => Process for preparation of O,O dimethyl phosphoramidothioate and N-(methoxymethylsulfanylphosphoryl) acetamide
[patent_app_type] => utility
[patent_app_number] => 16/860182
[patent_app_country] => US
[patent_app_date] => 2020-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2692
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16860182
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/860182 | Process for preparation of O,O dimethyl phosphoramidothioate and N-(methoxymethylsulfanylphosphoryl) acetamide | Apr 27, 2020 | Issued |
Array
(
[id] => 16206495
[patent_doc_number] => 20200239485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => THIOGLYCOLURIL COMPOUND, AND METHOD FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/849151
[patent_app_country] => US
[patent_app_date] => 2020-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3182
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16849151
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/849151 | Thioglycoluril compound, and method for producing same | Apr 14, 2020 | Issued |
Array
(
[id] => 16206400
[patent_doc_number] => 20200239390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-30
[patent_title] => METHOD FOR AROMATIC FLUORINATION
[patent_app_type] => utility
[patent_app_number] => 16/847193
[patent_app_country] => US
[patent_app_date] => 2020-04-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16847193
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/847193 | Method for aromatic fluorination | Apr 12, 2020 | Issued |
Array
(
[id] => 16360865
[patent_doc_number] => 20200317616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => Crystalline Form of Betrixaban Maleate
[patent_app_type] => utility
[patent_app_number] => 16/835377
[patent_app_country] => US
[patent_app_date] => 2020-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4689
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16835377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/835377 | Crystalline Form of Betrixaban Maleate | Mar 30, 2020 | Abandoned |